IAVI 005

Status:Completed

Phase:I

Principal Investigator(s):John Warin Ward

Objective:Evaluate the safety and immunogenicity of a prime-boost combination of a clade A HIV-DNA/MVA prime-boost combination in HIV-uninfected healthy volunteers at low risk for HIV infection

Prevention Option(s):HIV Vaccine

Study Design:Open label

Arms and Assigned Interventions

DescriptionOn days 0 and 21, participants who previously received a DNA vaccine in the trial IAVI 001 and who volunteer again will be boosted with 5 x10^7 pfu of HIV-MVA

Mode of DeliveryIntradermal

ARMs

Official Code: IAVI 005

Trial Sponsors: John Warin Ward, Medical Research Council (MRC)

Start Date

End Date

none

Enrollment:9

Age range: ↔ any

Population:

Stay up-to-date!